Immediate Impact
2 from Science/Nature 39 standout
Citing Papers
Development of NK cell-based cancer immunotherapies through receptor engineering
2024 Standout
Bispecific antibodies: advancing precision oncology
2024 Standout
Works of Aurélie Verney being referenced
Clinical outcome of patients with follicular lymphoma receiving chemoimmunotherapy in the PRIMA study is not affected by FCGR3A and FCGR2A polymorphisms
2012
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Aurélie Verney | 219 | 221 | 71 | 82 | 16 | 326 | |
| Pär Josefsson | 242 | 172 | 35 | 116 | 16 | 355 | |
| Daniel Painter | 243 | 133 | 71 | 159 | 11 | 342 | |
| Brian Munneke | 208 | 154 | 59 | 165 | 13 | 321 | |
| Anne Marie Boesen | 223 | 134 | 54 | 177 | 16 | 360 | |
| Jennifer L. Cultrera | 180 | 76 | 52 | 199 | 23 | 318 | |
| Yoshitomo Maesako | 165 | 109 | 105 | 112 | 16 | 353 | |
| Florence Broussais‐Guillaumot | 222 | 91 | 27 | 149 | 14 | 298 | |
| Blanche H. Mavromatis | 90 | 94 | 94 | 67 | 19 | 283 | |
| Paola Nanni | 171 | 162 | 60 | 95 | 13 | 301 | |
| N. L. Berinstein | 195 | 119 | 57 | 127 | 17 | 317 |
All Works
Loading papers...